Back to company

EUSA Pharma (Denmark) ApS: Financial statements 2019

CVR: 39055988

EUSA Pharma (Denmark) ApS (CVR 39055988) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,058,784 and a net result of DKK 228,408. Equity amounted to DKK 215,458. The solvency ratio was 24.2%. The company had 3 employees in the financial year.

Gross Profit
2,058,784 kr.
Profit/Loss
228,408 kr.
Equity
215,458 kr.
Total Assets
889,364 kr.
Employees
3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

EUSA Pharma (Denmark) ApS publishes interim reportMay 21, 2019

EUSA Pharma (Denmark) ApS has published its interim report for the period November 2, 2017 – December 31, 2018.

About EUSA Pharma (Denmark) ApS

EUSA Pharma (Denmark) ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017 and dissolved in 2024. The company was registered under the industry Reklamebureauer. In 2023, the company reported a gross profit of DKK 1,928,889 and a net result of DKK 141,012 compared with DKK 198,473 the year before. Equity amounted to DKK 1,644,740.

Other financial years